VRDN fund manager activity
Viridian Therapeutics, Inc · Nasdaq. Reported by 2 tracked fund managers in their 13F filings, Q4 2023 to Q2 2026.
Q4 2025
| Manager | Activity | Shares | Value | % of portfolio | Filed |
|---|---|---|---|---|---|
| Ken Fisher - Fisher Asset Management | Added | 1,780,284 | $55,402,437 | 0.02% | Feb 9, 2026 |
| Lee Ainslie - Maverick Capital | Sold out | — | — | 0.00% | Feb 13, 2026 |
Q3 2025
| Manager | Activity | Shares | Value | % of portfolio | Filed |
|---|---|---|---|---|---|
| Ken Fisher - Fisher Asset Management | Added | 1,201,226 | $25,922,455 | 0.01% | Nov 12, 2025 |
| Lee Ainslie - Maverick Capital | Trimmed | 2,212,701 | $47,750,088 | 0.64% | Nov 14, 2025 |